Explore Watchlists Pricing

FALCO HOLDINGS Co.,Ltd. (4671) Income statement

Market cap

¥28B

P/E ratio

12.8x

Provides clinical laboratory testing, pharmacy services, and medical IT systems to hospitals, clinics, and patients through specialized subsidiaries.

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2012/03	2013/03	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03	2021/03	2022/03	2023/03	2024/03	2025/03	2026/03
Revenue	60,828	62,758	58,401	46,593	48,727	45,971	45,962	44,156	43,185	43,608	50,007	46,913	43,007	43,313	43,578
Revenue growth (%)	-
Cost of revenue	-	-	-	33,068	34,380	32,243	32,279	31,382	30,848	29,910	32,683	32,269	30,084	29,956	29,766
Gross profit	-	-	-	13,524	14,346	13,728	13,683	12,774	12,337	13,698	17,323	14,644	12,923	13,357	13,811
Gross margin (%)	-	-	-
Operating margin (%)	-	-	-
Operating expenses	-	-	-	11,849	12,231	11,579	11,472	11,436	11,496	11,083	11,827	11,568	10,770	11,022	11,313
Operating income	-	-	-	1,675	2,114	2,148	2,211	1,338	841	2,614	5,496	3,075	2,152	2,335	2,498
Income before tax	2,085	2,186	1,118	1,825	2,229	2,269	2,385	1,632	941	2,853	5,809	3,310	2,288	2,499	2,689
Pretax margin (%)	3.4	3.5	1.9	3.9	4.6	4.9	5.2	3.7	2.2	6.5	11.6	7.1	5.3	5.8	6.2
Provision for income taxes	-	-	-	757	965	750	960	550	607	1,038	2,034	1,433	905	857	1,065
Effective tax rate (%)	-	-	-
Net income	491	814	3,793	1,117	1,347	1,478	1,697	653	1,243	1,853	3,533	2,261	1,666	1,920	1,987
Earnings per share	54.31	105.4	189.11	98.97	120.44	133.9	156.12	59.8	116.87	178.61	339	215.29	151.72	181.81	201.1
Diluted EPS	-	-	-	-	-	133.89	155.65	59.44	116.06	177.54	336.99	214.03	150.9	180.81	-
Dividend payout ratio (%)	-	-	-	-	-	-	-	-	-						-
Dividend per share	-	-	-	-	-	-	-	-	-	54	64	100	115	123	125